Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

No trades
See on Supercharts

Price target

124.870.00 0.00%
The 15 analysts offering 1 year price forecasts for AXSM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 16 analysts giving stock ratings to AXSM in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

AXSM EPS for the last quarter is −1.44 USD despite the estimation of −1.20 USD. In the next quarter EPS is expected to reach −1.30 USD. Track more of Axsome Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Axsome Therapeutics, Inc. revenue is expected to reach ‪87.24 M‬ USD. Check out Axsome Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, AXSM price target is 124.87 USD with a max estimate of 190.00 USD and a min estimate of 97.00 USD. Check if this forecast comes true in a year, meanwhile watch Axsome Therapeutics, Inc. stock price chart and keep track of the current situation with AXSM news and stock market news.
We've gathered opinions of 16 analysts rating AXSM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.